The University of Manchester has partnered with San Diego-based Agena Bioscience to help the school expand its educational resources in the area of pharmacogenomics. Pharmacogenomics is the study of how a person’s unique genetic makeup influences their response to drugs.
Agena is a global provider of genetic testing solutions.
The university offers a Graduate Certificate in PGx and a Master of Science in PGx. Manchester says the programs help healthcare professionals improve their clinical knowledge about PGx.
“Our relationship with Agena stems from the common goal of increasing awareness of pharmacogenetic testing and its importance to the future of precision medicine,” said W. Thomas Smith, Dean of Pharmacy and Human Sciences. life at the University of Manchester. “We believe pharmacogenomics will increasingly enable physicians and other clinicians to prescribe the right dose of the right drug at the right time, ultimately leading to better health care outcomes. “
The Graduate Certificate and Masters programs are taught online by the faculty of the University of Manchester.